IHE
iShares U.S. Pharmaceuticals ETF
Price Chart
Latest Quote
$100.92
+0.79 (+0.79%)
Current Price
| Previous Close | $100.13 |
| Open | $99.92 |
| Day High | $101.66 |
| Day Low | $99.92 |
| Volume | 104,382 |
Fund Information
| Quarterly Dividend / Yield | N/A / 1.48% |
| Net Assets | $1.14B |
| Expense Ratio | 0.38% |
| Category | Health |
| Fund Family | iShares |
| Net Asset Value | $99.88 |
| Premium/Discount | 1.04% |
| Quarterly Dividend Yield | 1.48% |
| P/E Ratio | 27.03 |
| Exchange | PCX |
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $100.92 | 105,500 |
| 2026-07-16 | $100.13 | 256,500 |
| 2026-07-15 | $98.99 | 168,600 |
| 2026-07-14 | $98.85 | 107,200 |
| 2026-07-13 | $99.99 | 87,800 |
| 2026-07-10 | $100.51 | 1,043,500 |
| 2026-07-09 | $102.22 | 1,007,300 |
| 2026-07-08 | $102.37 | 119,300 |
| 2026-07-07 | $103.42 | 701,300 |
| 2026-07-06 | $100.25 | 149,400 |
| 2026-07-02 | $100.96 | 884,600 |
| 2026-07-01 | $98.29 | 132,000 |
| 2026-06-30 | $99.01 | 98,400 |
| 2026-06-29 | $100.13 | 314,000 |
| 2026-06-26 | $99.13 | 114,600 |
| 2026-06-25 | $95.94 | 440,900 |
| 2026-06-24 | $95.08 | 436,900 |
| 2026-06-23 | $94.12 | 197,000 |
| 2026-06-22 | $92.64 | 70,300 |
| 2026-06-18 | $91.88 | 172,800 |
About iShares U.S. Pharmaceuticals ETF
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.
📰 Latest News
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Zacks • 2026-07-15T10:20:02ZHealthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge
Zacks • 2026-07-14T13:54:00ZInside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
Zacks • 2026-06-10T16:00:00ZMiddle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike
Zacks • 2026-06-09T13:59:00ZEven If Eli Lilly Stock Continues to Shine, Stay Away from This Pharmaceutical ETF
Barchart • 2026-06-02T19:02:50ZHealthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B Bet
Zacks • 2026-05-29T13:22:00ZDitch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
24/7 Wall St. • 2026-05-19T20:19:54ZThe Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics
Zacks • 2026-05-13T14:39:00ZIHE- As AI Speeds Drug Research, this Pharmaceutical ETF Should Prosper
MoneyShow • 2026-05-04T10:00:00ZHealthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move
Zacks • 2026-03-30T14:40:00Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.